Case Studies

News

A milestone towards advancing full reproductive agency for women across the world: WHO grants prequalification to first generic self-injectable contraceptive, increasing access to high-quality contraceptive choices

A milestone towards advancing full reproductive agency for women across the world: WHO grants prequalification to first generic self-injectable contraceptive, increasing access to high-quality contraceptive choices.

Our partners

Our work cuts across the entire healthcare value chain. We take a multi-disciplinary approach and apply our deep expertise to solve complex problems and bring about access to the latest and best health tools and service delivery models.

view our services

Featured Case Studies

Manufacturing

Strategy Development for Anti-Venom Commercialization

We developed a commercialization strategy for a scientific institution seeking to introduce new anti-venom therapeutics in Africa. By analyzing market access challenges, regulatory landscapes, and funding environments, MAA provided a framework prioritizing key countries for registration, ensuring a strategic, data-driven approach to improving anti-venom availability in the region.

Policy and Advocacy

Harnessing the Power of the Private Sector in the Fight Against Cervical Cancer

We partnered with a global health agency in engaging the private sector to expand access to HPV nucleic acid amplification tests (NAATs) for cervical cancer screening. Through market analysis, stakeholder consultations, and a policy discussion paper, we drove consensus on solutions to enhance affordability and availability in LMICs.

Policy and Advocacy

Best Practices for Strengthening African Regulatory Systems

We supported an international foundation in accelerating the domestication of the AU Model Law on Medical Products Regulation. Through in-depth analysis, stakeholder engagement, and policy recommendations, we developed a roadmap to streamline adoption, ensuring stronger regulatory systems, harmonisation, and improved access to safe, quality-assured medical products across Africa.

Maternal, Newborn and Child Health

Advocating for a Global Child Survival Action Movement

We supported a global taskforce in revitalizing child survival advocacy amid shifting global health priorities. This included developing a Blueprint for Child Survival Action and Advocacy, mobilizing key actors, securing investments, and embedding accountability mechanisms. This work positioned child survival as a policy priority across African and global health agendas.

Infectious Diseases

Advancing the Introduction of Innovative HIV Prevention Tools

Our partnership with a leading international financing organization help to inform the design of organizational investments supporting introduction of new HIV prevention tools

Infectious Diseases

Accelerating the Introduction of New TB Diagnostics at Primary Healthcare and Community Level

We conducted a comprehensive market analysis and developed a sizing model for third-generation LAM, near-POC, and PoC TB diagnostic products in target countries. Our insights on market dynamics, consumer preferences, and economic indicators enabled informed decision-making for the client and supported companies

Digital Heath

Supporting the Launch of a B2B Marketplace for Diagnostics in Kenya and Nigeria

Our market analysis in Kenya and Nigeria guided the rollout of a B2B marketplace connecting buyers and sellers of diagnostics, aiming to accelerate adoption of innovative tools. Insights led to an activation plan focusing on visibility, strategic positioning, and user engagement, ensuring the platform meets diverse market needs and sustains active participation

Neglected Diseases

Addressing the Challenges of Schistosomiasis Diagnosis

Our go-to-market strategy has developed a delivery blueprint with the potential to eradicate Schistosomiasis in Africa

Antimicrobial Resistance

Point of Care Antimicrobial Diagnostics in Low- and Middle-Income Countries

Our market landscape report provided crucial support for planning the commercialization of true and near point-of-care AMR diagnostic tests

Infectious Diseases

Go to Market Strategy for Non-sputum TB Assay

Our go-to-market strategy provided technical input in the development of a non-sputum TB molecular assay

Manufacturing

Design of an Innovative Path-Breaking Business Model for Pharmaceutical R&D and Manufacturing in Underserved LMIC markets

Market Access Africa developed an innovative business model designed to address the unmet need for diagnostic access, prioritizing people over profits and challenging conventional industry norms.

Infectious Diseases

Next Generation Tuberculosis Point of Care Test

Our go-to-market strategy helped our client prioritize and effectively plan the launch of their next-generation TB LAM product across Africa.

Non-communicable Diseases

Diagnosis of Hematologic Malignancies in LMICs

Our voice-of-the-customer assessment highlighted key health system priorities and user experiences in African countries, providing valuable insights into the diagnosis of hematologic malignancies across both public and private sectors.

Infectious Diseases

HIV Prevention through Self-Testing Kits

Our analysis of a total market approach for HIV self-tests assisted the Global Fund in developing sustainable strategies to expand access to self-testing kits and associated services across various market segments

Policy and Advocacy

Design of a Policy Initiative to Advance Equitable Global Health Governance Systems

A rapidly growing forum for collective action to tackle global problems and strengthen multilateral cooperation commissioned Market Access Africa to support the establishment of its health policy program...

Infectious Diseases

ARV Compliance Assay

Our partner in the medical device industry developed a simple point of care assay that detects the presence of tenofovir in a urine sample, providing instant results. Our go-to-market strategy helped to integrate a simple and cost-effective point of care tool to improve HIV treatment compliance.

Non-communicable Diseases

Expanding Point-of-Care Diagnostics for Non-Communicable Diseases in Africa

Market Access Africa's tailored market penetration strategies enabled a manufacturer of point-of-care diabetes diagnostic kits to refine their commercial approaches for each market, resulting in enhanced relationships with national and regional partners dedicated to non-communicable diseases (NCDs).

Manufacturing

Supporting the Commercialization of an African-made COVID-19 Diagnostic Kit

Our collaboration resulted in a robust business development plan that provided multiple pathways for product distribution, built brand awareness, and mitigated the risk of product expiry

Vaccines

Enhancing Cold Chain Monitoring for Health Commodities in Africa

Our comprehensive assessment of health commodity supply chains across ten African countries validated market launch plans for RTMD solutions, addressing critical gaps in cold chain logistics and reducing risks of spoilage. This strategic approach has positioned our client to sustainably engage key stakeholders and prioritize RTMDs in health commodity procurement and budgeting processes.

Neglected Diseases

Adapting a Product Development Partnership to New Challenges

A maturing R&D portfolio prompted a Product Development Partnership (PDP) to rethink its approach to access, necessitating the need for internal technical and surge support from Market Access Africa.

Maternal, Newborn and Child Health

Market-shaping strategy for reproductive, maternal and newborn health

Our product landscape and organizational strategy review led to the development of a market-shaping strategy for reproductive, maternal, and newborn health in Africa.

Neglected Diseases

Developing Better Treatments to Address the Scourge of Snakebites in Africa

Our comprehensive landscape assessment validated the viability of market launch strategy for a novel snakebite treatment formulation, effectively mitigating risks inherent in entering uncharted markets.

Diagnostic

Product Commercialization

Regulatory Affairs

Technical Assistance

Public Affairs & Advocacy

Case Studies

Explore a collection of content on issues we care about, the work we do, and our latest thinking across the organization.

A milestone towards advancing full reproductive agency for women across the world: WHO grants prequalification to first generic self-injectable contraceptive, increasing access to high-quality contraceptive choices

Our partners

Featured Case Studies

Strategy Development for Anti-Venom Commercialization

Harnessing the Power of the Private Sector in the Fight Against Cervical Cancer

Best Practices for Strengthening African Regulatory Systems

Advocating for a Global Child Survival Action Movement

Advancing the Introduction of Innovative HIV Prevention Tools

Accelerating the Introduction of New TB Diagnostics at Primary Healthcare and Community Level

Supporting the Launch of a B2B Marketplace for Diagnostics in Kenya and Nigeria

Addressing the Challenges of Schistosomiasis Diagnosis

Point of Care Antimicrobial Diagnostics in Low- and Middle-Income Countries

Go to Market Strategy for Non-sputum TB Assay

Design of an Innovative Path-Breaking Business Model for Pharmaceutical R&D and Manufacturing in Underserved LMIC markets

Next Generation Tuberculosis Point of Care Test

Diagnosis of Hematologic Malignancies in LMICs

HIV Prevention through Self-Testing Kits

Design of a Policy Initiative to Advance Equitable Global Health Governance Systems

ARV Compliance Assay

Expanding Point-of-Care Diagnostics for Non-Communicable Diseases in Africa

Supporting the Commercialization of an African-made COVID-19 Diagnostic Kit

Enhancing Cold Chain Monitoring for Health Commodities in Africa

Adapting a Product Development Partnership to New Challenges

Market-shaping strategy for reproductive, maternal and newborn health

Developing Better Treatments to Address the Scourge of Snakebites in Africa

For Press Inquiry Contact

Sign Up For Our Newsletter